Skip to main content
. 2022 Sep 15;9(9):474. doi: 10.3390/bioengineering9090474
CAR-T Chimeric Antigen Receptor T-Cell
CTLA-4 cytotoxic T-lymphocyte-associated protein 4
DOX Doxorubicin
HIFU High intensity focused ultrasound
HMGB1 High mobility group protein B1
HSPs Heat shock proteins
ICIs Immune checkpoint inhibitors
LITT Laser interstitial thermal therapy
MPH magnetic particle hyperthermia
MWA Microwave ablation
OS Overall survival
PD-1 Programmed cell death protein 1
PD-L1 Programmed death-ligand 1
PTT Photothermal therapy
RFA Radiofrequency ablation
TACE Transcatheter arterial chemoembolization
TAMs Tumor-associated macrophages
TARE Transarterial radioembolization